Which blood pressure drug saves more premature babies?
NCT ID NCT05347238
First seen Oct 16, 2026 · Last updated Oct 16, 2026
Summary
Very premature infants with late-onset sepsis often develop dangerously low blood pressure that does not respond to fluids. Doctors commonly use either dopamine or norepinephrine, but they lack clear evidence on which drug works better. This international study compares the two drugs across many hospitals to see which one leads to lower death rates and fewer treatment failures. The findings could help standardize care for these fragile infants.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dopamine or norepinephrine, two drugs that raise blood pressure
- What this could lead to
- If one drug proves better, hospitals could standardize treatment for low blood pressure in premature babies with sepsis, potentially improving survival.
- What could go wrong
- This is an observational comparison, not a randomized trial, so differences between hospitals could reflect other factors. The results may not apply to all preterm infants or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 550 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2023
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All preterm infants born ≤32 weeks gestational age and \> 48 hours of life with suspected sepsis with systemic hypotension admitted to the participating sites and meeting the above eligibility criteria will be included in the study.
- Ages
-
21 to 32 weeks
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ≤32 weeks gestational age and \> 48 hours of life * Receiving primary vasopressor therapy with Dopamine or Norepinephrine in the context of suspected late-onset sepsis or necrotizing enterocolitis with systemic hypotension (defined as: culture positive or negative bloodstream infection) Exclusion Criteria: * Known chromosomal or genetic anomalies * Receiving primary therapy with agents other than Dopamine or Norepinephrine
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Extreme prematurity are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
22 sites in 5 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
BC Women's Hospital
RECRUITINGVancouver, British Columbia, Canada
-
Banner-University Medical Center Phoenix
NOT_YET_RECRUITINGPhoenix, Arizona, 85006, United States
-
CHU Sainte- Justine
RECRUITINGMontreal, Quebec, Canada
-
Children's Hospital of Eastern Ontario
RECRUITINGOttawa, Ontario, Canada
-
Dayton Children's Hospital
RECRUITINGDayton, Ohio, 45404, United States
-
Foothill's Medical Centre
RECRUITINGCalgary, Alberta, Canada
-
Hospital for Sick Children
RECRUITINGToronto, Ontario, Canada
-
IWK Health Centre
RECRUITINGHalifax, Nova Scotia, Canada
-
Jewish General Hospital
RECRUITINGMontreal, Quebec, Canada
-
La Paz University Hospital
RECRUITINGMadrid, 28046, Spain
-
London Health Sciences Centre
RECRUITINGLondon, Ontario, Canada
-
McMaster Children's Hospital
RECRUITINGHamilton, Ontario, Canada
-
Methodist Healthcare
RECRUITINGSan Antonio, Texas, 78229, United States
-
Montreal Children's Hospital
RECRUITINGMontreal, Quebec, Canada
-
Mount Sinai Hospital
RECRUITINGToronto, Ontario, Canada
-
Shamir Medical Center
RECRUITINGBe’er Ya‘aqov, Israel
-
St.Boniface Hospital
NOT_YET_RECRUITINGWinnipeg, Manitoba, Canada
-
Sunnybrook Health Sciences Centre
RECRUITINGToronto, Ontario, Canada
-
University Cork College
RECRUITINGCork, Ireland
-
Victoria General Hospital
RECRUITINGVictoria, British Columbia, V8Z 6R5, Canada
-
Windsor Regional Hospital
RECRUITINGWindsor, Ontario, Canada
-
Winnipeg Health Sciences Centre
RECRUITINGWinnipeg, Manitoba, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can less oxygen at birth protect the tiniest Preemies' brains?
- Can a routine blood count signal sepsis in premature babies?
- Can timed lung 'Recruitment' maneuvers protect Preemies' lungs?
- New brain monitoring method may predict injury in tiniest newborns
- New blood markers could spot sepsis in newborns faster
- Premature baby brain drug fails in large trial